1146 results
-
List item
Management Board meeting: 16 March 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, 16/03/2023, Last updated: 20/03/2023 -
List item
Management Board meeting: 14-15 December 2022 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 14/12/2022 to 15/12/2022, Last updated: 23/02/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 February 2023 (updated)
European Medicines Agency, Amsterdam, the Netherlands, from 20/02/2023 to 23/02/2023, Last updated: 20/02/2023 -
List item
News: EMA confirms measures to minimise risk of serious side effects with Janus kinase inhibitors for chronic inflammatory disorders
CHMP, Last updated: 13/01/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 7-10 November 2022
European Medicines Agency, Amsterdam, the Netherlands, from 07/11/2022 to 10/11/2022, Last updated: 10/01/2023 -
List item
Committee for Medicinal Products for Human Use (CHMP): 10-13 October 2022
European Medicines Agency, Amsterdam, the Netherlands, from 10/10/2022 to 13/10/2022, Last updated: 23/11/2022 -
List item
News: EMA recommends approval of VidPrevtyn Beta as a COVID 19 booster vaccine
CHMP, Last updated: 11/11/2022 -
List item
Management Board meeting: 6 October 2022
European Medicines Agency, Amsterdam, the Netherlands, 06/10/2022, Last updated: 26/10/2022 -
List item
News: EMA recommends approval of Comirnaty and Spikevax COVID-19 vaccines for children from 6 months of age
CHMP, Last updated: 19/10/2022 -
List item
Management Board meeting: 15-16 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 15/06/2022 to 16/06/2022, Last updated: 12/10/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 August 2022
Written procedure, from 16/08/2022 to 19/08/2022, Last updated: 04/10/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 12-15 September 2022
CHMP, Last updated: 19/09/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 20-23 June 2022
European Medicines Agency, Amsterdam, the Netherlands, from 20/06/2022 to 23/06/2022, Last updated: 18/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 16-19 May 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/05/2022 to 19/05/2022, Last updated: 12/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 19-22 April 2022
European Medicines Agency, Amsterdam, the Netherlands, from 19/04/2022 to 22/04/2022, Last updated: 12/08/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 21-24 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 21/03/2022 to 24/03/2022, Last updated: 12/08/2022 -
List item
Management Board meeting: 16-17 March 2022
European Medicines Agency, Amsterdam, the Netherlands, from 16/03/2022 to 17/03/2022, Last updated: 07/07/2022 -
List item
News: Meeting highlights from the Committee for Medicinal Products for Human Use (CHMP) 24-27 January 2022
CHMP, Last updated: 05/07/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 24-27 January 2022
European Medicines Agency, Amsterdam, the Netherlands, from 24/01/2022 to 27/01/2022, Last updated: 16/03/2022 -
List item
News: COVID-19: EMA recommends conditional marketing authorisation for Paxlovid
CHMP, PRAC, Last updated: 28/01/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 8-11 November 2021
Online, from 08/11/2021 to 11/11/2021, Last updated: 20/01/2022 -
List item
Committee for Medicinal Products for Human Use (CHMP): 11-14 October 2021
European Medicines Agency, Amsterdam, the Netherlands, from 11/10/2021 to 14/10/2021, Last updated: 20/01/2022 -
List item
Management Board meeting: 7 October 2021
European Medicines Agency, Amsterdam, the Netherlands, 07/10/2021, Last updated: 18/01/2022 -
List item
Management Board meeting: 15-16 December 2021
European Medicines Agency, Amsterdam, the Netherlands, from 15/12/2021 to 16/12/2021, Last updated: 20/12/2021 -
List item
Committee for Medicinal Products for Human Use (CHMP): 17-20 May 2021
European Medicines Agency, Amsterdam, the Netherlands, from 17/05/2021 to 20/05/2021, Last updated: 07/12/2021